125 related articles for article (PubMed ID: 3740174)
21. Fluorometholone in children.
Novack GD
Ophthalmology; 2003 Jun; 110(6):1072-3; author reply 1073. PubMed ID: 12799226
[No Abstract] [Full Text] [Related]
22. Subtenon's depot corticosteroid injections in patients with a history of corticosteroid-induced intraocular pressure elevation.
Levin DS; Han DP; Dev S; Wirostko WJ; Mieler WF; Connor TB; George V; Eastwood D
Am J Ophthalmol; 2002 Feb; 133(2):196-202. PubMed ID: 11812422
[TBL] [Abstract][Full Text] [Related]
23. Effects of loteprednol/tobramycin versus dexamethasone/tobramycin on intraocular pressure in healthy volunteers.
Holland EJ; Bartlett JD; Paterno MR; Usner DW; Comstock TL
Cornea; 2008 Jan; 27(1):50-5. PubMed ID: 18245967
[TBL] [Abstract][Full Text] [Related]
24. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes.
Clark AF; Wilson K; de Kater AW; Allingham RR; McCartney MD
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):478-89. PubMed ID: 7843916
[TBL] [Abstract][Full Text] [Related]
25. Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification.
Trinavarat A; Atchaneeyasakul LO; Surachatkumtonekul T; Kosrirukvongs P
J Med Assoc Thai; 2003 Feb; 86(2):143-50. PubMed ID: 12678152
[TBL] [Abstract][Full Text] [Related]
26. The variant N363S of glucocorticoid receptor in steroid-induced ocular hypertension in Hungarian patients treated with photorefractive keratectomy.
Szabó V; Borgulya G; Filkorn T; Majnik J; Bányász I; Nagy ZZ
Mol Vis; 2007 Apr; 13():659-66. PubMed ID: 17563720
[TBL] [Abstract][Full Text] [Related]
27. Increased intraocular pressure induced by corticosteroids.
Kitazawa Y
Am J Ophthalmol; 1976 Sep; 82(3):492-5. PubMed ID: 961801
[TBL] [Abstract][Full Text] [Related]
28. Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after descemet membrane endothelial keratoplasty.
Price MO; Price FW; Kruse FE; Bachmann BO; Tourtas T
Cornea; 2014 Sep; 33(9):880-6. PubMed ID: 25062336
[TBL] [Abstract][Full Text] [Related]
29. Controlled comparison of two fluorometholone formulations in the antigen challenge model of allergic conjunctivitis.
Harper DG; Chen CE; Friedlaender MH
CLAO J; 1995 Oct; 21(4):256-60. PubMed ID: 8565196
[TBL] [Abstract][Full Text] [Related]
30. Marked intraocular pressure response to instillation of corticosteroids in children.
Ohji M; Kinoshita S; Ohmi E; Kuwayama Y
Am J Ophthalmol; 1991 Oct; 112(4):450-4. PubMed ID: 1928249
[TBL] [Abstract][Full Text] [Related]
31. A rabbit model of age-dependant ocular hypertensive response to topical corticosteroids.
Qin Y; Lam S; Yam GH; Choy KW; Liu DT; Chiu TY; Li WY; Lam DS; Pang CP; Fan DS
Acta Ophthalmol; 2012 Sep; 90(6):559-63. PubMed ID: 21044276
[TBL] [Abstract][Full Text] [Related]
32. Intraocular pressure response to topical dexamethasone as a predictor for the development of primary open-angle glaucoma.
Lewis JM; Priddy T; Judd J; Gordon MO; Kass MA; Kolker AE; Becker B
Am J Ophthalmol; 1988 Nov; 106(5):607-12. PubMed ID: 3189477
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of the effects of 0.1% bromfenac sodium eye drops and corticosteroids after small incision lenticule extraction].
Jiang Y; Li Y; Jin YM; Zhang JY
Zhonghua Yan Ke Za Zhi; 2017 Jan; 53(1):18-22. PubMed ID: 28162195
[No Abstract] [Full Text] [Related]
34. Efficacy and safety of long-term corticosteroid eye drops after penetrating keratoplasty: a prospective, randomized, clinical trial.
Shimazaki J; Iseda A; Satake Y; Shimazaki-Den S
Ophthalmology; 2012 Apr; 119(4):668-73. PubMed ID: 22264885
[TBL] [Abstract][Full Text] [Related]
35. Photorefractive keratectomy for myopia in 98 eyes.
Murta JN; Proenca R; Van Velze RA; Travassos A
J Refract Corneal Surg; 1994; 10(2 Suppl):S231-4. PubMed ID: 7517307
[TBL] [Abstract][Full Text] [Related]
36. Effect of topical anti-inflammatory treatment on the outcome of laser trabeculoplasty. The Fluorometholone-Laser Trabeculoplasty Study Group.
Shin DH; Frenkel RE; David R; Cheetham JK
Am J Ophthalmol; 1996 Sep; 122(3):349-54. PubMed ID: 8794707
[TBL] [Abstract][Full Text] [Related]
37. Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial.
Kass MA
Trans Am Ophthalmol Soc; 1989; 87():598-618. PubMed ID: 2562546
[TBL] [Abstract][Full Text] [Related]
38. Fluorometholone 0.1% as Ancillary Therapy for Trachomatous Trichiasis Surgery: Randomized Clinical Trial.
Kempen JH; Tekle-Haimanot R; Hunduma L; Alemayehu M; Pistilli M; Abashawl A; Lawrence SD; Alemayehu W
Am J Ophthalmol; 2019 Jan; 197():145-155. PubMed ID: 30267699
[TBL] [Abstract][Full Text] [Related]
39. Enhanced acute ocular hypotensive response to timolol with dexamethasone treatment.
Rom M; Schwartz B; Bealka N
J Glaucoma; 1997 Apr; 6(2):111-6. PubMed ID: 9098819
[TBL] [Abstract][Full Text] [Related]
40. SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension.
Malclès A; Dot C; Voirin N; Vié AL; Agard É; Bellocq D; Denis P; Kodjikian L
Retina; 2017 Jul; 37(7):1352-1359. PubMed ID: 27768641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
